title: The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil.
abstract: Brazil has an aging population, with an associated increase in the prevalence of chronic diseases. Postmenopausal osteoporosis is of particular concern because it leads to an increased risk of fractures, with subsequent negative impacts on health in older women. In recent years, efforts have been made to better understand the epidemiology of osteoporosis in Brazil, and to manage both direct and indirect costs to the Brazilian health care system. The reported prevalence of osteoporosis among postmenopausal women in Brazil varies from 15% to 33%, depending on the study methodology and the use of bone densitometry data or self-reporting by participants. A diagnosis of osteoporosis can be made on the basis of fractures occurring without significant trauma or on the basis of low bone mineral density measured by dual energy X-ray absorptiometry. To reduce the risk of osteoporosis, all postmenopausal women should be encouraged to maintain a healthy lifestyle, which includes physical activity and a balanced diet. Smoking and alcohol use should also be addressed. Special attention should be given to interventions to reduce the risk of falls, especially among older women. Calcium intake should be encouraged, preferably through diet. The decision to recommend calcium supplementation should be made individually because there is concern about a possible increased risk of cardiovascular disease associated with this treatment. Brazilian women obtain a minimal amount of vitamin D from their diet, and supplementation is warranted in women with little exposure to solar ultraviolet-B radiation. For women diagnosed with osteoporosis, some form of pharmacologic therapy should be initiated. Compliance with treatment should be monitored, and the treatment period should be individualized for each patient. The Brazilian government provides medication for osteoporosis through the public health system free of charge, but without proper epidemiological knowledge, the implementation of public health programs is impaired.
authors.affiliation: Department of Gynecology, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.
authors.forename: Luiz Francisco
authors.initials: LF
authors.lastname: Baccaro
authors.affiliation: Breast Clinic, Hospital for Maternal and Child Healthcare, Goiânia, Goiás, Brazil.
authors.forename: Délio Marques
authors.initials: DM
authors.lastname: Conde
authors.affiliation: Department of Gynecology, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.
authors.forename: Lúcia
authors.initials: L
authors.lastname: Costa-Paiva
authors.affiliation: Department of Gynecology, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.
authors.forename: Aarão Mendes
authors.initials: AM
authors.lastname: Pinto-Neto
mesh_terms: D000368:Aged; D001938:Brazil / Q000453:epidemiology; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis / Q000453:epidemiology* / Q000209:etiology / Q000628:therapy; D012307:Risk Factors
keywords: disease management; menopause; preventive medicine; public health; risk factors
references.citation: Cochrane Database Syst Rev. 2004;(1):CD004526
references.pmid: 14974070
references.citation: JAMA. 1999 Aug 18;282(7):637-45
references.pmid: 10517716
references.citation: Ann Intern Med. 1991 Jun 1;114(11):919-23
references.pmid: 2024857
references.citation: J Bone Miner Res. 1994 Aug;9(8):1137-41
references.pmid: 7976495
references.citation: Osteoporos Int. 2000;11(1):83-91
references.pmid: 10663363
references.citation: Am J Med. 2000 Sep;109(4):267-76
references.pmid: 10996576
references.citation: JAMA. 2001 Feb 14;285(6):785-95
references.pmid: 11176917
references.citation: N Engl J Med. 2001 May 10;344(19):1434-41
references.pmid: 11346808
references.citation: JAMA. 2002 Jul 17;288(3):321-33
references.pmid: 12117397
references.citation: Osteoporos Int. 2002 Nov;13(11):907-13
references.pmid: 12415439
references.citation: Neth J Med. 2002 Sep;60(8):315-9
references.pmid: 12481878
references.citation: Bone. 2003 Sep;33(3):293-300
references.pmid: 13678769
references.citation: N Engl J Med. 2004 Jan 29;350(5):459-68
references.pmid: 14749454
references.citation: Osteoporos Int. 1994 Nov;4(6):368-81
references.pmid: 7696835
references.citation: Lancet. 1996 Dec 7;348(9041):1535-41
references.pmid: 8950879
references.citation: J Bone Miner Res. 1998 Mar;13(3):325-49
references.pmid: 9525333
references.citation: JAMA. 1998 Dec 23-30;280(24):2077-82
references.pmid: 9875874
references.citation: JAMA. 1999 Jun 16;281(23):2189-97
references.pmid: 10376571
references.citation: J Natl Cancer Inst. 2004 Dec 1;96(23):1751-61
references.pmid: 15572757
references.citation: J Clin Endocrinol Metab. 2005 May;90(5):2816-22
references.pmid: 15728210
references.citation: Osteoporos Int. 2005 Nov;16(11):1451-60
references.pmid: 15711778
references.citation: JAMA. 2006 Jun 21;295(23):2727-41
references.pmid: 16754727
references.citation: N Engl J Med. 2007 May 3;356(18):1809-22
references.pmid: 17476007
references.citation: J Bone Miner Res. 2008 Jan;23(1):112-20
references.pmid: 17892376
references.citation: Curr Med Res Opin. 2008 Jan;24(1):237-45
references.pmid: 18047776
references.citation: J Bone Miner Res. 2007 Dec;22 Suppl 2:V28-33
references.pmid: 18290718
references.citation: Osteoporos Int. 2008 Apr;19(4):385-97
references.pmid: 18292978
references.citation: Nutr J. 2009;8:6
references.pmid: 19178745
references.citation: Cochrane Database Syst Rev. 2009;(2):CD007146
references.pmid: 19370674
references.citation: N Engl J Med. 2009 Aug 20;361(8):756-65
references.pmid: 19671655
references.citation: Rev Saude Publica. 2009 Nov;43 Suppl 2:107-16
references.pmid: 19936505
references.citation: Arch Intern Med. 2009 Dec 14;169(22):2087-94
references.pmid: 20008691
references.citation: J Clin Endocrinol Metab. 2010 Apr;95(4):1555-65
references.pmid: 20173017
references.citation: Calcif Tissue Int. 2010 Jun;86(6):421-35
references.pmid: 20407762
references.citation: Rev Saude Publica. 2010 Jun;44(3):479-85
references.pmid: 20549019
references.citation: BMJ. 2010;341:c3691
references.pmid: 20671013
references.citation: Rev Bras Reumatol. 2010 Mar-Apr;50(2):113-27
references.pmid: 21125148
references.citation: Lancet. 2011 Jun 4;377(9781):1949-61
references.pmid: 21561658
references.citation: Menopause. 2011 May;18(5):531-6
references.pmid: 21242816
references.citation: J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30
references.pmid: 21646368
references.citation: Rev Bras Ginecol Obstet. 2011 Jun;33(6):295-302
references.pmid: 21877019
references.citation: Osteoporos Int. 2012 Apr;23(4):1371-9
references.pmid: 21769663
references.citation: Am J Cardiovasc Drugs. 2012 Apr 1;12(2):105-16
references.pmid: 22283597
references.citation: Menopause. 2012 Sep;19(9):989-94
references.pmid: 22668820
references.citation: Rev Saude Publica. 2012 Dec;46(6):1030-8
references.pmid: 23503540
references.citation: Arch Osteoporos. 2013;8:138
references.pmid: 23575503
references.citation: Rev Saude Publica. 2013 Apr;47(2):390-402
references.pmid: 24037367
references.citation: Osteoporos Int. 2013 Oct;24(10):2707-12
references.pmid: 23632825
references.citation: Osteoporos Int. 2014 Aug;25(8):2047-56
references.pmid: 24803331
references.citation: Arq Bras Endocrinol Metabol. 2014 Jul;58(5):411-33
references.pmid: 25166032
references.citation: Arq Bras Endocrinol Metabol. 2014 Jul;58(5):434-43
references.pmid: 25166033
references.citation: Osteoporos Int. 2014 Oct;25(10):2359-81
references.pmid: 25182228
references.citation: Rev Bras Epidemiol. 2014 Jul-Sep;17(3):719-34
references.pmid: 25272264
references.citation: J Bone Miner Res. 2014 Nov;29(11):2520-6
references.pmid: 24771492
references.citation: J Bone Miner Res. 2004 Aug;19(8):1241-9
references.pmid: 15231010